Status:

COMPLETED

Vascular Endothelium Changes After Bariatric Surgery (Endothelial Progenitor Cells)

Lead Sponsor:

University of South Alabama

Collaborating Sponsors:

American Society for Metabolic and Bariatric Surgery

Conditions:

Type 2 Diabetes

Eligibility:

All Genders

19-65 years

Phase:

NA

Brief Summary

Improvement in cardiovascular mortality is related to changes in pathologic autoantibodies and in the number of circulating functional replicative competent endothelial progenitor cells (EPC's) after ...

Detailed Description

Same as above

Eligibility Criteria

Inclusion

  • Type 2 Diabetes, Glucose \> 200mg/dl, currently be ing treated with oral medications and HGA1c . 6.5, and BMI .35.

Exclusion

  • Type 1 Diabetes

Key Trial Info

Start Date :

September 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2014

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT01213940

Start Date

September 1 2010

End Date

May 1 2014

Last Update

May 9 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of South Alabama

Mobile, Alabama, United States, 36617

Vascular Endothelium Changes After Bariatric Surgery (Endothelial Progenitor Cells) | DecenTrialz